Clinical Trial Update: Nivo40-AVD for Advanced Classic Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nivolumab plus AVD (Nivo40-AVD) in adults with advanced classic Hodgkin lymphoma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• Doxorubicin (doxorubicin)
• Vinblastine (vinblastine)
• nivolumab (nivolumab)

Snippet

Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia | Conditions: Hodgkin Lymphoma, Adult | Phase 2 | Status: RECRUITING